Leukemogenesis by CBF oncoproteins
- 1 December 1999
- journal article
- review article
- Published by Springer Nature in Leukemia
- Vol. 13 (12) , 1932-1942
- https://doi.org/10.1038/sj.leu.2401590
Abstract
The AML1 and CBFβ subunits of core binding factor (CBF) are involved in several chromosomal abnormalities frequently associated with acute leukemias. As a result, the CBFβ-SMMHC, AML1-ETO and AML1-MDS1/EVI1 fusion proteins are expressed in subsets of acute myeloid leukemia, and TEL-AML1 is expressed in B-lineage acute lymphocytic leukemia. These CBF oncoproteins likely contribute to leukemogenesis in part by inhibiting endogenous CBF. As a result they are expected to inhibit differentiation and perhaps apoptosis. In addition, the domains unique to each fusion protein may also contribute to leukemogenesis via unique mechanisms.Keywords
This publication has 0 references indexed in Scilit: